Edoxudine

DERMATOLOGICALS

Key facts

Edoxudine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including UL23.

• Molecular targets: UL23 (1 listed in DrugCentral).
• ATC code: D06BB09 (Antivirals).
• Molecular formula: C11H16N2O5; molecular weight 256.26 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Thymidine kinase	UL23	unknown	IC50 6.82

ATC classification

ATC code	Therapeutic hierarchy
D06BB09	DERMATOLOGICALS › ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE › CHEMOTHERAPEUTICS FOR TOPICAL USE › Antivirals

Chemical structure

• Molecular formula: C₁₁H₁₆N₂O₅
• Molecular weight: 256.26 g/mol
• CAS number: 15176-29-1
• InChIKey: XACKNLSZYYIACO-DJLDLDEBSA-N
• PubChem CID: 66377

CCC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Edoxudine work?

Its molecular targets in DrugCentral include UL23.

What is the chemical formula of Edoxudine?

Edoxudine has the molecular formula C11H16N2O5 and a molecular weight of 256.26 g/mol.

Sources

• DrugCentral drug card 3173 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL318153 — compound record and bioactivity
• PubChem CID 66377 — chemical identifiers
• DrugBank DB13421 — drug record
• FDA UNII 15ZQM81Y3R — substance identity

How this page is built: methodology · editorial policy & corrections.